Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Shree Ganesh Remedies Ltd has approved the re-appointment of Mr. Parth Chandulal Kothia as a Whole Time Director and Chief Financial Officer (KMP) for a further period of 5 years, effective January 17, 2026 to January 16, 2031, subject to shareholder approval. Mr. Parth is a Chemical Engineering graduate with a Master's in Global Finance from Fordham University, USA, and has been with the company since 2021. He is the son of Mr. Chandulal Manubhai Kothia, the Chairman and Managing Director, and holds 131,704 equity shares in the company. The board also confirmed that Mr. Parth and other directors are not debarred by SEBI or any other authority from holding directorship.
This is a routine re-appointment with no change in leadership or governance structure, so it is unlikely to have a material impact on the stock price. Shareholders will get to vote on the re-appointment at the next general meeting.